Ventana News
Most Popular Ventana Story
Roche nabs the $3.4B Ventana prize
Don't play cards with Ventana CEO Christopher Gleeson (photo). He might poker-face you into sweetening the pot, just as he finally has with Roche. Yes, after months of fairly believable bluffing, the... Read more...
Latest Headlines
- October 29, 2008
- February 8, 2008
- January 23, 2008
- January 22, 2008
- November 8, 2007
- October 10, 2007
- September 20, 2007
- August 22, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
